Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/a Martindale Pharma, Xaggitin XL Prolonged-release Tablets, El(26)a/35
Summary Xaggitin XL Prolonged-release Tablets made by Macarthys Laboratories Ltd (trading as Martindale Pharma) are being recalled in the United Kingdom because some bottles contain incorrect numbers of tablets. This affects multiple batches of the medication.
- Recalling firm
- Macarthys Laboratories Ltd T/A Martindale Pharma
- Reason
- Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in the bottles.
- Classification
- Class III
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2026-07-20
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/e1437594-67a6-4d3f-a6f1-2031882d5c66